论文部分内容阅读
一、前言睑板腺癌是原发于眼睑麦氏腺的恶性肿瘤。它虽然是比较少见的疾病,但在眼睑的恶性肿瘤中发病率却是相当高的。我院从1972年10月—1980年9月共收治经病理证实的眼睑恶性肿瘤50例,其中睑板腺癌20例占40％,居第一位。此种疾病早期在临床上难以与睑板腺囊肿区別,最易误诊。我院遇到的20例中有7例(35％)曾在外院诊为脸板腺囊肿而做了囊肿单纯刮除术(这当然不能完全排除当时就是单纯的囊肿)。本病晚期临床上又常与眼睑鳞癌或基底细胞癌相混淆。我院20例中有5例临床诊断为癌,1例为眼睑肿物,2例以疑似睑板腺癌而入院,诊断附合率占
I. INTRODUCTION The meibomian gland cancer is a malignancy that originates in the eyelid’s Maier’s gland. Although it is a relatively rare disease, the incidence in malignant tumors of the eyelids is quite high. In our hospital, from October 1972 to September 1980, 50 cases of orbital malignant tumors were confirmed. Among them, 20 cases of meibomian adenocarcinomas accounted for 40%, ranking the first. The early stage of this disease is difficult to distinguish from the meibomian gland cyst in clinical practice, and is most often misdiagnosed. Seven of the 20 cases (35%) encountered in our hospital had a simple cyst curettage at the out-patient clinic for facial cheek cysts (which, of course, could not completely rule out a simple cyst at the time). The disease is often confused with eyelid squamous cell carcinoma or basal cell carcinoma in the late stage of clinical practice. Of the 20 cases in our hospital, 5 cases were clinically diagnosed as cancer, 1 case was an orbital mass, 2 cases were admitted to hospital with suspected meibomian adenocarcinoma, and diagnostic apposition rates accounted for 5 cases.